Acumen Pharmaceuticals Inc Share Price

NASDAQ: ABOS

Small Cap

$1.26

-0.06

(-4.17%)

as on September 16, 2025 at 1:29 am IST

$₹

Acumen Pharmaceuticals Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
Day's High
$1.22
Day's Price Range
$1.36
$1.26
3.17%
Downside
7.94%
Upside
52 Week's Low
52 Week's High
$0.86
52-Week Price Range
$3.36
$1.26
32.13%
Downside
166.67%
Upside

Acumen Pharmaceuticals Inc share price movements today

Previous Close: $1.32
Open: $1.33
Volume: 475.5K
Day's Low - High: $1.22 - $1.36
52 Week Low - High: $0.86 - $3.36

Acumen Pharmaceuticals Inc Historical Returns

1 Month Return: -7.04 %
3 Month Return: + 23.36 %
1 Year Return: -49.23 %
3 Year Return: -78.64 %
5 Year Return: 0 %

Acumen Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Acumen Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$80.0M

EPS (TTM)

-2.1947

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-143.9M

Revenue (TTM)

329.0K

Profit Margin

0.00%

Return On Equity TTM

157886400.00%

Acumen Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Acumen Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Acumen Pharmaceuticals Inc	BUY	$80.0M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Acumen Pharmaceuticals Inc Stock including INR - Dollar returns

The Acumen Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Acumen Pharmaceuticals Inc investment value today

Current value as on today

₹53,447

Returns

₹46,553

(-46.55%)

Returns from Acumen Pharmaceuticals Inc Stock

₹51,538 (-51.54%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Acumen Pharmaceuticals Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Acumen Pharmaceuticals Inc. Average target price of $7.6

Acumen Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Acumen Pharmaceuticals Inc.

What analysts predicted

83.42%UPSIDE

Target Price

$7.6

Current Price

$1.26

Analyzed by

12 Analysts

Target

$7.60

Acumen Pharmaceuticals Inc target price $7.6, a slight upside of 83.42% compared to current price of $1.26. According to 12 analysts rating.

Acumen Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Acumen Pharmaceuticals Inc Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:-67% versus previous 30 day period

Acumen Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	-	-	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	-
Operating Income	-13	-13	-16	-18	-17	-24	-32	-39	-30	-41
EBITDA	-11	-11	-16	-15	-13	-19	-28	-36	-27	-41
Interest Expense	1	1	-	0	1	1	1	1	1	1
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-11	-11	-12	-16	-14	-20	-29	-37	-28	-40
Income Tax Expense	-1	-1	0	3	0	-	-	0	-	-
Net Income	-9	-11	-12	-16	-14	-20	-29	-37	-28	-40
Net Profit Margin	0.00%	0.00%	0.00%	-5688.62%	0.00%	0.00%	0.00%	-20873.03%	0.00%	0.00%

Acumen Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	1	1	1	-	-	-
Gross Profit	1	-6	0	0	-42	0
Operating Income	-7	-7	-19	-45	-61	-114
EBITDA	0	-7	-19	-42	-51	-98
Interest Expense	-	-	81	2	0	4
Depreciation	-	-	0	0	0	0
Income Before Tax	-7	-7	-100	-42	-52	-102
Income Tax Expense	0	0	81	-2	-	-
Net Income	-7	-7	-100	-42	-52	-102
Net Profit Margin	-465.94%	-510.10%	-7005.99%	0.00%	0.00%	0.00%

Acumen Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-11	-12	-16	-14	-20	-29	-37	-28	-40
Operating Cash Flow	-11	-12	-8	-17	-16	-24	-27	-34	-31
Investing Cash Flow	11	-92	-48	-9	37	-10	29	28	38
Financing Cash Flow	0	122	29	7	0	0	0	0	-
Change in Cash	0	17	-27	-19	21	-34	2	-5	6

Acumen Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-7	-100	-42	-52	-102
Operating Cash Flow	-7	-17	-35	-43	-86
Investing Cash Flow	-104	-104	39	-171	48
Financing Cash Flow	44	200	3	151	6
Change in Cash	37	78	7	-62	-31

Global Institutional Holdings in Acumen Pharmaceuticals Inc

Funds	Holdings
RA Capital Management, LLC	24.65%
Sands Capital Ventures, LLC	5.64%
Franklin Resources Inc	5.19%
BlackRock Inc	3.85%
FMR Inc	3.34%

See all

Insights on Acumen Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 193.5%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 121.0%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ABOS stock has moved down by -12.5%

About Acumen Pharmaceuticals Inc

acumen is forging a new path towards safe and effective treatments for alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta oligomers. our founders pioneered seminal discoveries and methods to understand the role of toxic amyloid-beta oligomers (aβo) in synaptic dysfunction and neurodegeneration. these early insights have fostered decades of research on the biology of aβo at acumen and throughout the field. we are now on the on cusp of realizing the therapeutic potential of aβo targeted drugs.

Organisation	Acumen Pharmaceuticals Inc
Headquarters	1210-1220 Washington St., Newton, MA, United States, 02465
Industry	Healthcare
CEO	Mr. Daniel J. O'Connell M.B.A.
E-voting on shares	Click here to vote

Key Management of Acumen Pharmaceuticals Inc

Name	Title
Mr. Daniel J. O'Connell M.B.A.	CEO & Director
Dr. Grant A. Krafft Ph.D.	Co-Founder
Dr. William L. Klein Ph.D.	Co-Founder
Mr. Russell Barton M.S.	Chief Operating Officer
Mr. Derek M. Meisner Esq., J.D.	Chief Legal Officer & Corporate Secretary
Dr. James Doherty Ph.D.	President & Chief Development Officer
Mr. Matt Zuga	CFO & Chief Business Officer
Dr. Caleb E. Finch Ph.D.	Co-Founder
Ms. Kelly Carranza	Vice President, Finance & Accounting and Corporate Controller
Ms. Alex Braun M.B.A.	VP & Head of Investor Relations

FAQs

What is Acumen Pharmaceuticals Inc share price today?

Acumen Pharmaceuticals Inc share price today is $1.26 as on September 16, 2025 at 1:29 am IST at the close of the market. Acumen Pharmaceuticals Inc share today touched a day high of $1.36 and a low of $1.22.

What is the 52 week high and 52 week low for Acumen Pharmaceuticals Inc share?

Acumen Pharmaceuticals Inc share touched a 52 week high of $3.36 on November 11, 2024 and a 52 week low of $0.86 on April 21, 2025. Acumen Pharmaceuticals Inc stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $1.26,which is 62.50% down from its 52 week high and 47.35% up from its 52 week low.

What is Acumen Pharmaceuticals Inc's market capitalisation today?

Acumen Pharmaceuticals Inc market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Acumen Pharmaceuticals Inc Stock (ABOS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Acumen Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Acumen Pharmaceuticals Inc Shares that will get you 1.1905 shares as per Acumen Pharmaceuticals Inc share price of $1.26 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Acumen Pharmaceuticals Inc Stock (ABOS) from India?

Indian investors can start investing in Acumen Pharmaceuticals Inc (ABOS) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 2:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Acumen Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 2:41 pm IST). Based on Acumen Pharmaceuticals Inc share’s latest price of $1.26 as on September 16, 2025 at 1:29 am IST, you will get 7.9365 shares of Acumen Pharmaceuticals Inc. Learn more about fractional shares .